- Previous close
89.29 - Open
89.56 - Bid --
- Ask --
- Day's range
88.60 - 89.98 - 52-week range
62.35 - 94.55 - Volume
1,209,275 - Avg. Volume
2,780,940 - Market cap (intra-day)
40.597B - Beta (5Y monthly) --
- PE ratio (TTM)
25.69 - EPS (TTM)
3.46 - Earnings date 30 Oct 2024
- Forward dividend & yield 0.12 (0.13%)
- Ex-dividend date 18 Oct 2024
- 1y target est
96.14
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
www.gehealthcare.com51,000
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Health Information Services
Industry
Recent news: GEHC
View more
Performance overview: GEHC
Trailing total returns as of 24/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: GEHC
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: GEHC
View moreValuation measures
Market cap
40.78B
Enterprise value
48.44B
Trailing P/E
25.81
Forward P/E
19.23
PEG ratio (5-yr expected)
2.34
Price/sales (ttm)
2.10
Price/book (mrq)
5.23
Enterprise value/revenue
2.48
Enterprise value/EBITDA
13.97
Financial highlights
Profitability and income statement
Profit margin
8.09%
Return on assets (ttm)
5.73%
Return on equity (ttm)
21.22%
Revenue (ttm)
19.52B
Net income avi to common (ttm)
1.58B
Diluted EPS (ttm)
3.46
Balance sheet and cash flow
Total cash (mrq)
2B
Total debt/equity (mrq)
120.87%
Levered free cash flow (ttm)
1.96B